Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study

Clinical Infectious Diseases, Volume 60, No. 12, Year 2015

In STRIDE, slow metabolizer CYP2B6 and NAT2 genotypes were each associated with increased plasma efavirenz concentrations during antituberculosis therapy. Concentrations were greater on therapy than off therapy in 58% with CYP2B6 and 93% with NAT2 slow metabolizer genotypes. Individuals with slow metabolizer genotypes in both genes had markedly elevated concentrations.

Statistics
Citations: 10
Authors: 10
Affiliations: 8
Identifiers
Doi: 10.1093/cid/civ155
ISSN: 10584838
e-ISSN: 15376591
Research Areas
Genetics And Genomics

Disclaimer

All information and calculations provided are based on our current indexed publications and may change as more data is collected.

African Research Nexus

The African Research Nexus is a visionary initiative that seeks to increase the visibility of African Researchers and Institutions. We are a dynamic hub designed to transform the African research landscape and amplify the voices of our continent’s brightest minds.

Useful Links

ABOUT US
PROFILES
Authors Directory
AI Digest
CONTACT US

Subscribe Now
Don’t miss our future updates!

Follow Us